title: Fibrohistiocytic tumors in a lung transplant patient taking oral capecitabine for nonmelanoma skin cancer chemoprevention.
authors.affiliation: Department of Dermatology, Howard University College of Medicine, Washington, District of Columbia Department of Dermatology, Columbia University Medical Center, New York, New York Comprehensive Skin Cancer Center, Mount Sinai Beth Israel Medical Center, New York, New York.
authors.forename: Sailesh
authors.initials: S
authors.lastname: Konda
authors.forename: Vishal A
authors.initials: VA
authors.lastname: Patel
authors.forename: Kevin W
authors.initials: KW
authors.lastname: O'Bryan
authors.forename: Desiree
authors.initials: D
authors.lastname: Ratner
mesh_terms: D017255:Acitretin / Q000627:therapeutic use; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D000069287:Capecitabine; D002280:Basal Cell Carcinoma / Q000517:prevention & control* / Q000601:surgery; D002294:Carcinoma, Squamous Cell / Q000517:prevention & control* / Q000532:radiotherapy / Q000601:surgery; D003841:Deoxycytidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D017809:Fatal Outcome; D005472:Fluorouracil / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006086:Graft vs Host Disease / Q000209:etiology; D006258:Head and Neck Neoplasms / Q000601:surgery*; D051677:Histiocytoma, Malignant Fibrous / Q000601:surgery*; D006801:Humans; D007641:Keratolytic Agents / Q000627:therapeutic use; D016040:Lung Transplantation / Q000009:adverse effects; D008297:Male; D012878:Skin Neoplasms / Q000517:prevention & control* / Q000601:surgery
chemical_list: D000964:Antimetabolites, Antineoplastic; D007641:Keratolytic Agents; D003841:Deoxycytidine; D000069287:Capecitabine; D017255:Acitretin; D005472:Fluorouracil